Palivizumab Injection

PALIVIZUMAB (pal i VI zu mab) prevents severe infections caused by the respiratory syncytial virus (RSV). It does not treat RSV. It is still possible to get RSV after receiving this medication, but the symptoms may be less severe or not last as long. It works by helping your immune system slow or stop the spread of the virus in the body. It is a monoclonal antibody.

This medication is for injection into a muscle. It is given by your care team in a hospital or clinic setting.

Talk to your care team about the use of this medication in children. While it may be prescribed for children as young as premature newborns for selected conditions, precautions do apply.

Side effects that you should report to your care team as soon as possible:

• Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
• Unusual bruising or bleeding

Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):

• Fever
• Pain, redness, or irritation at injection site

This medication is given in a hospital or clinic. It will not be stored at home.

They need to know if your child has any of these conditions:

• Bleeding disorders
• Immune system problems
• An unusual or allergic reaction to palivizumab, vaccines or antibodies, other medications, foods, dyes, or preservatives

Interactions are not expected.

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

See your care team for monthly injections of this medication as directed.